AstraZeneca PLC (AZN) Cash Flow Quarterly - Discounting Cash Flows
AZN
AstraZeneca PLC
AZN (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-30
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
2014 (Q4)
12-31
2014 (Q3)
09-30
2014 (Q2)
06-30
2014 (Q1)
03-31
2013 (Q4)
12-31
2013 (Q3)
09-30
2013 (Q2)
06-30
2013 (Q1)
03-31
2012 (Q4)
12-31
2012 (Q3)
09-30
2012 (Q2)
06-30
2012 (Q1)
03-31
2011 (Q4)
12-31
2011 (Q3)
09-30
2011 (Q2)
06-30
2011 (Q1)
03-31
2010 (Q4)
12-31
2010 (Q3)
09-30
2010 (Q2)
06-30
2010 (Q1)
03-31
2009 (Q4)
12-31
2009 (Q3)
09-30
2009 (Q2)
06-30
2009 (Q1)
03-31
2008 (Q4)
12-31
2008 (Q3)
09-30
2008 (Q2)
06-30
2008 (Q1)
03-31
2007 (Q4)
12-31
2007 (Q3)
09-30
2007 (Q2)
06-30
2007 (Q1)
03-31
2006 (Q4)
12-31
2006 (Q3)
09-30
2006 (Q2)
06-30
2006 (Q1)
03-31
2005 (Q4)
12-31
2005 (Q3)
09-30
2005 (Q2)
06-30
2005 (Q1)
03-31
2004 (Q4)
12-31
2004 (Q3)
09-30
2004 (Q2)
06-30
2004 (Q1)
03-31
2003 (Q4)
12-31
2003 (Q3)
09-30
2003 (Q2)
06-30
2003 (Q1)
03-31
2002 (Q4)
12-31
2002 (Q3)
09-30
2002 (Q2)
06-30
2002 (Q1)
03-31
2001 (Q4)
12-31
2001 (Q3)
09-30
2001 (Q2)
06-30
2001 (Q1)
03-31
2000 (Q4)
12-31
2000 (Q3)
09-30
2000 (Q2)
06-30
2000 (Q1)
03-31
1999 (Q4)
12-31
1999 (Q3)
09-30
Report Filing: 2025-11-06 2025-11-06 2025-07-29 2025-03-30 2025-02-18 2024-09-30 2024-06-30
1234
Net Income/Starting Line 10,242 2,533 3,127 2,916 1,666 1,828 2,397
1234
Cash From Operating Activities 15,140 5,134 3,386 3,713 2,907 3,383 3,085
1234
Depreciation and Amortization 4,936 1,549 1,389 1,284 714 1,817 1,279
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 0 0 0 0 0 0 0
1234
Other Non-Cash Items 248 217 -785 -61 877 -303 -462
1234
Changes in Working Capital -286 835 -345 -426 -350 41 -129
1234
Accounts Receivable 0 0 0 0 0 0 0
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable 0 0 0 0 0 0 0
1234
Deferred Revenue -286 835 -345 -426 -350 41 -129
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -6,543 -2,001 -2,108 -1,253 -1,181 -1,514 -2,872
1234
Investments in Property Plant and Equipment -2,482 -686 -659 -429 -708 -417 -382
1234
Payments for Acquisitions -1,231 -328 -267 -362 -274 -281 -2,297
1234
Purchases of Securities -188 0 -188 0 0 -29 31
1234
Sales and Maturities of Investments 82 0 114 0 -32 47 84
1234
Other Investing Activities -2,724 -987 -1,108 -462 -167 -834 -308
1234
Cash From Financing Activities -4,933 -2,073 518 -2,707 -671 -4,131 -1,222
1234
Debt Repayment 1,026 -93 632 1,095 -608 -2,419 -1,134
1234
Common Stock Issued -454 0 1 -478 23 -77 5
1234
Common Stock Repurchased -19 -19 0 0 0 0 0
1234
Dividends Paid -4,971 -1,611 -10 -3,347 -3 -1,576 -17
1234
Other Financing Activities -515 -350 -105 23 -83 -59 -76
1234
Effect of Forex Changes on Cash -19 -12 29 25 -61 20 -6
1234
Net Change in Cash 2,651 1,048 1,825 -222 994 -2,242 -1,015
1234
Cash at Beginning of Period 5,429 7,032 5,207 5,429 4,435 6,677 7,692
1234
Cash at End of Period 8,080 8,080 7,032 5,207 5,429 4,435 6,677
1234
Free Cash Flow 11,147 4,448 1,463 3,284 1,952 2,025 2,417
1234
Operating Cash Flow 15,140 5,134 3,386 3,713 2,907 3,383 3,085
1234
Capital Expenditure -3,993 -686 -1,923 -429 -955 -1,358 -668
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program